Compare CADL & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | NIU |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 275.6M |
| IPO Year | 2021 | 2018 |
| Metric | CADL | NIU |
|---|---|---|
| Price | $5.89 | $3.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $19.43 | N/A |
| AVG Volume (30 Days) | ★ 743.5K | 448.3K |
| Earning Date | 03-12-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $625,182,280.00 |
| Revenue This Year | N/A | $42.51 |
| Revenue Next Year | N/A | $17.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 50.99 |
| 52 Week Low | $4.25 | $1.93 |
| 52 Week High | $13.68 | $5.67 |
| Indicator | CADL | NIU |
|---|---|---|
| Relative Strength Index (RSI) | 50.24 | 53.78 |
| Support Level | $5.91 | $3.00 |
| Resistance Level | $6.62 | $3.26 |
| Average True Range (ATR) | 0.38 | 0.16 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 32.57 | 69.23 |
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.